These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 8099558

  • 1. [Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators].
    Jacob BG, Richter WO, Schwandt P.
    Fortschr Med; 1993 Mar 20; 111(8):126-9. PubMed ID: 8099558
    [Abstract] [Full Text] [Related]

  • 2. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P, de Courten M, Ferrari P, Böhlen L.
    J Cardiovasc Pharmacol; 1993 Mar 20; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [Abstract] [Full Text] [Related]

  • 3. Side effects of antihypertensive drugs.
    Chrysant SG, Frohlich ED.
    Am Fam Physician; 1974 Jan 20; 9(1):94-101. PubMed ID: 4149117
    [No Abstract] [Full Text] [Related]

  • 4. Direct Vasodilators and Sympatholytic Agents.
    McComb MN, Chao JY, Ng TM.
    J Cardiovasc Pharmacol Ther; 2016 Jan 20; 21(1):3-19. PubMed ID: 26033778
    [Abstract] [Full Text] [Related]

  • 5. Effects of antihypertensive drugs on lipid metabolism.
    Leren P.
    Clin Ther; 1987 Jan 20; 9(3):326-32. PubMed ID: 2886221
    [Abstract] [Full Text] [Related]

  • 6. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W, Müller-Wieland D, Nägele H, Behnke B, Greten H.
    J Cardiovasc Pharmacol; 1987 Jan 20; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [Abstract] [Full Text] [Related]

  • 7. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
    Kincaid-Smith P.
    J Hum Hypertens; 1989 Dec 20; 3 Suppl 2():75-83. PubMed ID: 2575178
    [Abstract] [Full Text] [Related]

  • 8. Metabolic changes during antihypertensive therapies.
    Krone W, Nägele H.
    J Hum Hypertens; 1989 Dec 20; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 20; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 10. Urapidil, a dual-acting antihypertensive agent: Current usage considerations.
    Buch J.
    Adv Ther; 2010 Jul 20; 27(7):426-43. PubMed ID: 20652659
    [Abstract] [Full Text] [Related]

  • 11. Blood lipids and antihypertensive drugs. The Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Pharmacol; 1983 Jul 20; 14 Suppl 2():217-20. PubMed ID: 6632918
    [Abstract] [Full Text] [Related]

  • 12. Adverse effects of antihypertensive treatment.
    Materson BJ.
    Cardiol Clin; 1986 Feb 20; 4(1):105-15. PubMed ID: 2871930
    [Abstract] [Full Text] [Related]

  • 13. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P, Ferrier C, Saxenhofer H, Uehlinger DE, Trost BN.
    Drugs; 1988 Feb 20; 35 Suppl 6():118-34. PubMed ID: 3042351
    [Abstract] [Full Text] [Related]

  • 14. Hypertension and CHD risk: whither alpha-1 blockers?
    Pandit RB.
    Indian Heart J; 1996 Feb 20; 48(3):265-71. PubMed ID: 8755013
    [Abstract] [Full Text] [Related]

  • 15. [Modification of lipoprotein metabolism by antihypertensive therapy].
    Herrmann W, Reuter W.
    Z Gesamte Inn Med; 1989 Apr 01; 44(7):197-200. PubMed ID: 2662653
    [Abstract] [Full Text] [Related]

  • 16. Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.
    Chernow B, Zaloga GP, Lake CR, Coleman MD, Ziegler MG.
    Fed Proc; 1984 Jan 01; 43(1):72-7. PubMed ID: 6317467
    [Abstract] [Full Text] [Related]

  • 17. Use of sympatholytic and vasodilator drugs.
    Moyer JH.
    Pa Med; 1984 Jan 01; 87(1):34-42. PubMed ID: 6144088
    [No Abstract] [Full Text] [Related]

  • 18. Meta-analysis of studies using selective alpha1-blockers in patients with hypertension and type 2 diabetes.
    Glanz M, Garber AJ, Mancia G, Levenstein M.
    Int J Clin Pract; 2001 Dec 01; 55(10):694-701. PubMed ID: 11777296
    [Abstract] [Full Text] [Related]

  • 19. [Interference with lipid metabolism by various antihypertensive agents: facts and hypotheses].
    Rouffy J.
    Arch Mal Coeur Vaiss; 1987 Apr 01; 80 Spec No():43-6. PubMed ID: 2887148
    [Abstract] [Full Text] [Related]

  • 20. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
    Hoogenberg K, van der Tuin J.
    Ned Tijdschr Geneeskd; 2002 Nov 02; 146(44):2099-100. PubMed ID: 12448967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.